Q3 2016 Iran
Total Page:16
File Type:pdf, Size:1020Kb
Q3 2016 www.bmiresearch.com IRAN PHARMACEUTICALS & HEALTHCARE REPORT INCLUDES 10-YEAR FORECASTS TO 2025 Published by:BMI Research Iran Pharmaceuticals & Healthcare Report Q3 2016 INCLUDES 10-YEAR FORECASTS TO 2025 Part of BMI’s Industry Report & Forecasts Series Published by: BMI Research Copy deadline: May 2016 ISSN: 1748-1953 BMI Research © 2016 Business Monitor International Ltd Senator House All rights reserved. 85 Queen Victoria Street London All information contained in this publication is EC4V 4AB copyrighted in the name of Business Monitor United Kingdom International Ltd, and as such no part of this Tel: +44 (0) 20 7248 0468 publication may be reproduced, repackaged, Fax: +44 (0) 20 7248 0467 redistributed, resold in whole or in any part, or used Email: [email protected] in any form or by any means graphic, electronic or Web: http://www.bmiresearch.com mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. DISCLAIMER All information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, in view of the natural scope for human and/or mechanical error, either at source or during production, Business Monitor International Ltd accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is provided without warranty, and Business Monitor International Ltd makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained. Iran Pharmaceuticals & Healthcare Report Q3 2016 CONTENTS BMI Industry View ............................................................................................................... 7 Table: Headline Pharmaceuticals & Healthcare Forecasts (Iran 2014-2020) ......................................................................... 7 SWOT .................................................................................................................................... 9 Industry Forecast .............................................................................................................. 12 Pharmaceutical Market Forecast ................................................................................................................ 12 Table: Pharmaceutical Sales, Historical Data And Forecasts (Iran 2012-2020) ...................................................................... 15 Healthcare Market Forecast ...................................................................................................................... 16 Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2012-2020) ........................................................... 18 Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2012-2020) .............................................. 19 Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2012-2020) ................................................... 20 Prescription Drug Market Forecast ............................................................................................................ 21 Patented Drug Market Forecast ................................................................................................................. 23 Generic Drug Market Forecast .................................................................................................................. 24 OTC Market Forecast ............................................................................................................................... 25 Pharmaceutical Trade Forecast ................................................................................................................. 26 Table: Pharmaceutical Trade Data And Forecasts (Iran 2014-2020) ................................................................................. 29 Table: Pharmaceutical Trade Data And Forecasts local currency (Iran 2014-2020) ................................................................. 29 Industry Risk/Reward Index ............................................................................................. 30 Middle East and Africa Risk/Reward Index - Q3 2016 ..................................................................................... 30 Iran Risk/Reward Index ............................................................................................................................ 38 Rewards ............................................................................................................................................... 38 Risks .................................................................................................................................................... 39 Regulatory Review ............................................................................................................ 40 Intellectual Property Issues ...................................................................................................................... 42 Pricing & Reimbursement Regime ............................................................................................................. 44 Market Overview ............................................................................................................... 46 Healthcare Sector .................................................................................................................................. 47 Table: Healthcare Resources (Iran 2010-2015) ........................................................................................................ 50 Table: Healthcare Personnel (Iran 2010-2015) ........................................................................................................ 50 Table: Healthcare Activity (Iran 2010-2015) ........................................................................................................... 51 Research & Development ........................................................................................................................ 54 Clinical Trials ....................................................................................................................................... 58 Epidemiology ........................................................................................................................................ 58 Competitive Landscape .................................................................................................... 62 Research-Based Industry ......................................................................................................................... 62 Table: Multinational Company Activity ................................................................................................................ 65 Generic Drugmakers .............................................................................................................................. 66 © Business Monitor International Ltd Page 4 Iran Pharmaceuticals & Healthcare Report Q3 2016 Table: Leading Drug Manufacturers, Iran - To March 2009 .......................................................................................... 66 Pharmaceutical Distribution .................................................................................................................... 69 Table: Leading Distributors, Iranian - Year To March 20 2008 ....................................................................................... 70 Pharmaceutical Retail Sector ................................................................................................................... 71 Table: Tehran Stock Exchange - Listed Pharmaceutical Companies As Of November 2015 .......................................................... 71 Company Profile ................................................................................................................ 73 Caspian Tamin Pharmaceutical Company .................................................................................................... 73 Darou Pakhsh ......................................................................................................................................... 76 Exir Pharmaceuticals ............................................................................................................................... 79 Pars Darou ............................................................................................................................................ 82 Zahravi Pharmaceutical Company .............................................................................................................. 84 Demographic Forecast ..................................................................................................... 87 Table: Population Headline Indicators (Iran 1990-2025) .............................................................................................. 88 Table: Key Population Ratios (Iran 1990-2025) ....................................................................................................... 88 Table: Urban/Rural Population & Life Expectancy (Iran 1990-2025) ................................................................................. 89 Table: Population By Age Group (Iran 1990-2025) ...................................................................................................